Friday, March 13, 2015 10:10:12 AM
I have not doubt on your long position in NWBO, and many posters in this board. I know many people tend to catch up with already formed pattern which you accurately depicted in your reply, hoping to make repeated trade to increase profit or at least increase share counts by buying low and selling high.
Well, that strategy is no longer useful one, and the pattern of the past, in my opinion has long gone as some institutions have truly shown their interests and increased their positions.
Other institutions will follow just as most retail investors tend to follow the tide up not buy at valley. The recent days of pause of buying may just be faked pause, and we will see it very clearly within short period of time.
This is 2015, not 2014 nor 2013, a year full of catalysts and ever clear picture of high chance of successes of nwbo in both DCVax-L and DCVax-D.
Any traders will tend to trade less and less, and new positions from both institutions and retail will pile on if usual trading pattern for a biotech company also holds true in the case of nwbo.
I see no sign of otherwise, but steady build up in both share counts and share price from institutions and retail investors.
If many believe what I believe, i.e., I believe nwbo will ultimately success in its DCVax platform if this definite signs is not known this year, it will be known early next year.
In general, I don't think people want to be left out of this wonderful journey towards success; I don't think institutions holders want to see their bet doubted by their clients and the general market, unless they all want to get in more cheap and resort in dirty tactics of manipulation.
I see none of that in face of Woodford.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM